Literature DB >> 18340466

A new mechanism of dominance in hypophosphatasia: the mutated protein can disturb the cell localization of the wild-type protein.

A S Lia-Baldini1, I Brun-Heath, C Carrion, B Simon-Bouy, J L Serre, M E Nunes, E Mornet.   

Abstract

The dominant negative effect of mutations is rare in metabolic diseases and its mechanism has not been studied much. Hypophosphatasia, a bone inherited metabolic disorder, is a good model because the disease can be dominantly transmitted. The gene product activity depends on a homodimeric configuration and many mutations have been reported in the ALPL gene responsible for the disease. Using CFP/YFP-tagged-TNSALP plasmids, transfections in COS cells and confocal fluorescence analyses, we studied the point mutation G232V (c.746G>T). We showed that the G232V protein sequestrates some of the wild-type protein into the cells and prevents it from reaching the membrane where it plays its physiological role.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18340466     DOI: 10.1007/s00439-008-0480-1

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  8 in total

1.  Mammalian alkaline phosphatases are allosteric enzymes.

Authors:  M F Hoylaerts; T Manes; J L Millán
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

2.  Retention at the cis-Golgi and delayed degradation of tissue-non-specific alkaline phosphatase with an Asn153-->Asp substitution, a cause of perinatal hypophosphatasia.

Authors:  Masahiro Ito; Norio Amizuka; Hidehiro Ozawa; Kimimitsu Oda
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 3.  Functional inactivation of genes by dominant negative mutations.

Authors:  I Herskowitz
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

4.  A molecular approach to dominance in hypophosphatasia.

Authors:  A S Lia-Baldini; F Muller; A Taillandier; J F Gibrat; M Mouchard; B Robin; B Simon-Bouy; J L Serre; A S Aylsworth; E Bieth; S Delanote; P Freisinger; J C Hu; H P Krohn; M E Nunes; E Mornet
Journal:  Hum Genet       Date:  2001-07       Impact factor: 4.132

Review 5.  Molecular mechanism of dominant expression in 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  M R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

6.  Asp361Val Mutant of alkaline phosphatase found in patients with dominantly inherited hypophosphatasia inhibits the activity of the wild-type enzyme.

Authors:  H L Müller; M Yamazaki; T Michigami; T Kageyama; E Schönau; P Schneider; K Ozono
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

7.  Delayed transport of tissue-nonspecific alkaline phosphatase with missense mutations causing hypophosphatasia.

Authors:  Isabelle Brun-Heath; Anne-Sophie Lia-Baldini; Stéphane Maillard; Agnès Taillandier; Boris Utsch; Mark E Nunes; Jean-Louis Serre; Etienne Mornet
Journal:  Eur J Med Genet       Date:  2007-07-21       Impact factor: 2.708

8.  Phosphatidylinositol anchor of HeLa cell alkaline phosphatase.

Authors:  R Jemmerson; M G Low
Journal:  Biochemistry       Date:  1987-09-08       Impact factor: 3.162

  8 in total
  12 in total

1.  Rare coding variants in ALPL are associated with low serum alkaline phosphatase and low bone mineral density.

Authors:  Carrie M Nielson; Joseph M Zmuda; Amy S Carlos; Wendy J Wagoner; Emily A Larson; Eric S Orwoll; Robert F Klein
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

2.  Clinical utility gene card for: hypophosphatasia.

Authors:  Etienne Mornet; Christine Beck; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer
Journal:  Eur J Hum Genet       Date:  2010-10-27       Impact factor: 4.246

3.  Clinical utility gene card for: hypophosphatasia - update 2013.

Authors:  Etienne Mornet; Christine Hofmann; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer
Journal:  Eur J Hum Genet       Date:  2013-08-07       Impact factor: 4.246

4.  Genetic analysis of adults heterozygous for ALPL mutations.

Authors:  Agnès Taillandier; Christelle Domingues; Annika Dufour; Françoise Debiais; Pascal Guggenbuhl; Christian Roux; Catherine Cormier; Bernard Cortet; Valérie Porquet-Bordes; Fabienne Coury; David Geneviève; Jean Chiesa; Thierry Colin; Elaine Fletcher; Agnès Guichet; Rose-Marie Javier; Michel Laroche; Michael Laurent; Ekkehart Lausch; Bruno LeHeup; Cédric Lukas; Georg Schwabe; Ineke van der Burgt; Christine Muti; Brigitte Simon-Bouy; Etienne Mornet
Journal:  J Bone Miner Metab       Date:  2017-12-13       Impact factor: 2.626

Review 5.  Disorders of phosphate homeostasis in children, part 1: primer on mineral ion homeostasis and the roles of phosphate in skeletal biology.

Authors:  Richard M Shore
Journal:  Pediatr Radiol       Date:  2022-05-10

6.  Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia.

Authors:  Lothar Seefried; Jasmin Baumann; Sarah Hemsley; Christine Hofmann; Erdmute Kunstmann; Beate Kiese; Yue Huang; Simon Chivers; Marie-Anne Valentin; Babul Borah; Ronenn Roubenoff; Uwe Junker; Franz Jakob
Journal:  J Clin Invest       Date:  2017-04-24       Impact factor: 14.808

Review 7.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

8.  Large-scale in vitro functional testing and novel variant scoring via protein modeling provide insights into alkaline phosphatase activity in hypophosphatasia.

Authors:  Guillermo Del Angel; John Reynders; Christopher Negron; Thomas Steinbrecher; Etienne Mornet
Journal:  Hum Mutat       Date:  2020-03-18       Impact factor: 4.878

9.  Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles.

Authors:  Delphine Fauvert; Isabelle Brun-Heath; Anne-Sophie Lia-Baldini; Linda Bellazi; Agnès Taillandier; Jean-Louis Serre; Philippe de Mazancourt; Etienne Mornet
Journal:  BMC Med Genet       Date:  2009-06-06       Impact factor: 2.103

10.  Genetic evaluations of Chinese patients with odontohypophosphatasia resulting from heterozygosity for mutations in the tissue-non-specific alkaline phosphatase gene.

Authors:  Jia Wan; Li Zhang; Tang Liu; Yewei Wang
Journal:  Oncotarget       Date:  2017-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.